{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T14:11:35Z","timestamp":1794924695785,"version":"4.9.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T00:00:00Z","timestamp":1705622400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Hepatology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.aohep.2024.101288","type":"journal-article","created":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T19:41:33Z","timestamp":1706125293000},"page":"101288","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Lean non-alcoholic fatty liver disease and the risk of all-cause mortality: An updated meta-analysis"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9732-6354","authenticated-orcid":false,"given":"Wasit","family":"Wongtrakul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6472-7511","authenticated-orcid":false,"given":"Natthinee","family":"Charatcharoenwitthaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8334-0267","authenticated-orcid":false,"given":"Phunchai","family":"Charatcharoenwitthaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.aohep.2024.101288_bib0001","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S2213-8587(18)30154-2","article-title":"Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies","volume":"7","author":"Stefan","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"10.1016\/j.aohep.2024.101288_bib0002","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of non-alcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.aohep.2024.101288_bib0003","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/hep.25762","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association","volume":"55","author":"Chalasani","year":"2012","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.aohep.2024.101288_bib0004","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","article-title":"Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Non-alcoholic Fatty Liver Disease","volume":"149","author":"Angulo","year":"2015","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.aohep.2024.101288_bib0005","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1136\/gutjnl-2020-322786","article-title":"Mortality in biopsy-confirmed non-alcoholic fatty liver disease: results from a nationwide cohort","volume":"70","author":"Simon","year":"2021","journal-title":"Gut"},{"issue":"8","key":"10.1016\/j.aohep.2024.101288_bib0006","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S2468-1253(20)30077-7","article-title":"Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"5","author":"Ye","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.aohep.2024.101288_bib0007","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/hep.28697","article-title":"Histological severity and clinical outcomes of non-alcoholic fatty liver disease in nonobese patients","volume":"65","author":"Leung","year":"2017","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.aohep.2024.101288_bib0008","doi-asserted-by":"crossref","first-page":"e311","DOI":"10.1016\/S0618-8278(19)30608-5","article-title":"THU-345-Lean NAFLD patients have lower prevalence of cardiovascular, metabolic and severe liver disease compared to overweight or obese patients with NAFLD","volume":"70","author":"Weinberg","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2024.101288_bib0009","doi-asserted-by":"crossref","unstructured":"Dela Cruz A.C., Bugianesi E., George J., Day C.P., Liaquat H., Charatcharoenwitthaya P., et al. Characteristics and long-term prognosis of lean patients with non-alcoholic fatty liver disease. Gastroenterology 2014;146(5):S\u2013909. https:\/\/doi.org\/10.1016\/S0016-5085(14)63307-2.","DOI":"10.1016\/S0016-5085(14)63307-2"},{"issue":"6","key":"10.1016\/j.aohep.2024.101288_bib0010","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.cgh.2021.07.016","article-title":"Natural History of Non-alcoholic Fatty Liver Disease With Normal Body Mass Index: a Population-Based Study","volume":"20","author":"Ahmed","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.aohep.2024.101288_bib0011","doi-asserted-by":"crossref","first-page":"366","DOI":"10.15403\/jgld-3622","article-title":"Liver-related mortality is increased in lean subjects with non- alcoholic fatty liver disease compared to overweight and obese subjects","volume":"30","author":"Feldman","year":"2021","journal-title":"J Gastrointestin Liver Dis"},{"issue":"8","key":"10.1016\/j.aohep.2024.101288_bib0012","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1002\/hep4.1534","article-title":"Mortality of NAFLD according to the body composition and presence of metabolic abnormalities","volume":"4","author":"Golabi","year":"2020","journal-title":"Hepatol Commun"},{"issue":"1","key":"10.1016\/j.aohep.2024.101288_bib0013","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/hep4.1124","article-title":"Risk for development of severe liver disease in lean patients with non-alcoholic fatty liver disease: a long-term follow-up study","volume":"2","author":"Hagstr\u00f6m","year":"2018","journal-title":"Hepatol Commun"},{"issue":"11","key":"10.1016\/j.aohep.2024.101288_bib0014","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0241770","article-title":"Nineteen-year prognosis in Japanese patients with biopsy-proven non-alcoholic fatty liver disease: lean versus overweight patients","volume":"15","author":"Hirose","year":"2020","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.aohep.2024.101288_bib0015","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/s12072-021-10143-4","article-title":"The epidemiology of NAFLD and lean NAFLD in Japan: a meta-analysis with individual and forecasting analysis, 1995-2040","volume":"15","author":"Ito","year":"2021","journal-title":"Hepatol Int"},{"issue":"5","key":"10.1016\/j.aohep.2024.101288_bib0016","doi-asserted-by":"crossref","first-page":"S1201","DOI":"10.1016\/S0016-5085(17)33999-9","article-title":"Lean patients with non-alcoholic fatty liver disease have worse survival rates, higher frequency of cirrhosis, and decompensation compared to non-lean patients","volume":"152","author":"Mansour","year":"2017","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.aohep.2024.101288_bib0017","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1136\/gutjnl-2020-322564","article-title":"Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach?","volume":"71","author":"Younes","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.aohep.2024.101288_bib0018","first-page":"S1542","article-title":"Mortality and liver-related events in lean versus non-lean non-alcoholic fatty liver disease: a systematic review and meta-analysis","author":"Ha","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.aohep.2024.101288_bib0019","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1002\/jcsm.13001","article-title":"Muscle strength, but not body mass index, is associated with mortality in patients with non-alcoholic fatty liver disease","volume":"13","author":"Charatcharoenwitthaya","year":"2022","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"12","key":"10.1016\/j.aohep.2024.101288_bib0020","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.1002\/hep4.2081","article-title":"Outcomes of subjects who are lean, overweight or obese with non-alcoholic fatty liver disease: a cohort study in China","volume":"6","author":"Lan","year":"2022","journal-title":"Hepatol Commun"},{"issue":"1","key":"10.1016\/j.aohep.2024.101288_bib0021","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/HEP.0000000000000329","article-title":"Lean individuals with NAFLD have more severe liver disease and poorer clinical outcomes (NASH-CO Study)","volume":"78","author":"Nabi","year":"2023","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.aohep.2024.101288_bib0022","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1111\/apt.17424","article-title":"Higher mortality among lean patients with non-alcoholic fatty liver disease despite fewer metabolic comorbidities","volume":"57","author":"Wijarnpreecha","year":"2023","journal-title":"Aliment Pharmacol Ther"},{"issue":"76","key":"10.1016\/j.aohep.2024.101288_bib0023","first-page":"S742","article-title":"Cirrhosis incidence and long-term mortality rate among lean, overweight, and obese patients with non-alcoholic fatty liver disease (NAFLD) in the United States","author":"Nguyen","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2024.101288_bib0024","unstructured":"Wells G.A., Shea B., O'Connell D., Peterson J., Welch V., Losos M., et al. The Newcastle\u2013Ottawa scale (NOS) for assessing the quality of non-randomized studies in meta-analysis. 2000."},{"issue":"3","key":"10.1016\/j.aohep.2024.101288_bib0025","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"issue":"7414","key":"10.1016\/j.aohep.2024.101288_bib0026","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"issue":"9","key":"10.1016\/j.aohep.2024.101288_bib0027","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/hep4.1105","article-title":"Progression of liver fibrosis is associated with non-liver-related mortality in patients with non-alcoholic fatty liver disease","volume":"1","author":"Tada","year":"2017","journal-title":"Hepatol Commun"},{"issue":"1","key":"10.1016\/j.aohep.2024.101288_bib0028","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/jgh.14448","article-title":"Utility and limitations of noninvasive fibrosis markers for predicting prognosis in biopsy-proven Japanese non-alcoholic fatty liver disease patients","volume":"34","author":"Ito","year":"2019","journal-title":"J Gastroenterol Hepatol"},{"issue":"7156","key":"10.1016\/j.aohep.2024.101288_bib0029","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1136\/bmj.317.7156.468","article-title":"Time to event (survival) data","volume":"317","author":"Altman","year":"1998","journal-title":"BMJ (Clinical research ed)"},{"issue":"9","key":"10.1016\/j.aohep.2024.101288_bib0030","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1210\/clinem\/dgab339","article-title":"Metabolic dysfunction-associated fatty liver disease (MAFLD)-rather a bystander than a driver of mortality","volume":"106","author":"Semmler","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.aohep.2024.101288_bib0031","doi-asserted-by":"crossref","first-page":"620","DOI":"10.14309\/ajg.0000000000000074","article-title":"Alcoholic and non-alcoholic fatty liver disease and liver-related mortality: a cohort study","volume":"114","author":"Chang","year":"2019","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.aohep.2024.101288_bib0032","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/joim.13069","article-title":"Prevalence, characteristics and mortality outcomes of obese, nonobese and lean NAFLD in the United States, 1999-2016","volume":"288","author":"Zou","year":"2020","journal-title":"J Intern Med"},{"issue":"1","key":"10.1016\/j.aohep.2024.101288_bib0033","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/liv.15078","article-title":"Association of genetic variations with NAFLD in lean individuals","volume":"42","author":"Lin","year":"2022","journal-title":"Liver Int"},{"issue":"7","key":"10.1016\/j.aohep.2024.101288_bib0034","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/1751-2980.12871","article-title":"Epidemiology of non-alcoholic fatty liver disease in non-obese populations: meta-analytic assessment of its prevalence, genetic, metabolic, and histological profiles","volume":"21","author":"Zou","year":"2020","journal-title":"J Dig Dis"},{"key":"10.1016\/j.aohep.2024.101288_bib0035","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3389\/fmed.2019.00304","article-title":"PNPLA3-a potential therapeutic target for personalized treatment of chronic liver disease","volume":"6","author":"Dong","year":"2019","journal-title":"Front Med (Lausanne)"},{"issue":"5","key":"10.1016\/j.aohep.2024.101288_bib0036","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.cgh.2020.04.058","article-title":"PNPLA3 gene polymorphism and liver- and extrahepatic cancer-related mortality in the United States","volume":"19","author":"Wijarnpreecha","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.aohep.2024.101288_bib0037","article-title":"Comparative burden of metabolic dysfunction in lean NAFLD vs non-lean NAFLD - a systematic review and meta-analysis","author":"Tang","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.aohep.2024.101288_bib0038","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/hep4.1818","article-title":"Risk of cardiovascular disease in individuals with nonobese non-alcoholic fatty liver disease","volume":"6","author":"Arvind","year":"2022","journal-title":"Hepatol Commun"}],"container-title":["Annals of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S166526812400005X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S166526812400005X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T10:46:29Z","timestamp":1761648389000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S166526812400005X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S166526812400005X"],"URL":"https:\/\/doi.org\/10.1016\/j.aohep.2024.101288","relation":{},"ISSN":["1665-2681"],"issn-type":[{"value":"1665-2681","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lean non-alcoholic fatty liver disease and the risk of all-cause mortality: An updated meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Annals of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aohep.2024.101288","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Fundaci\u00f3n Cl\u00ednica M\u00e9dica Sur, A.C. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"101288"}}